Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: BIOMARCADORES, ANESTÉSICOS, ALUCINOGÊNICOS, DEPRESSÃO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
ABNT
ROSSI, Giordano Novak et al. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01460-2. Acesso em: 20 abr. 2024.APA
Rossi, G. N., Hallak, J. E. C., Baker, G., Dursun, S. M., & Santos, R. G. dos. (2023). The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience. doi:10.1007/s00406-022-01460-2NLM
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ;[citado 2024 abr. 20 ] Available from: https://doi.org/10.1007/s00406-022-01460-2Vancouver
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ;[citado 2024 abr. 20 ] Available from: https://doi.org/10.1007/s00406-022-01460-2